GuidelineCurrent

ATS/ERS/JRS/ALAT 2022 — Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis Clinical Practice Guideline

ATS/ERS/JRS/ALAT, 2022

Fibrotic ILD management depends on phenotype and progression; in acute ICU deterioration, evaluate infection, edema, PE and pneumothorax while recognizing the poor prognosis of invasive ventilation in advanced irreversible fibrosis without a reversible bridge or transplant strategy.

Conditional recommendationModerate certainty

View source guideline

Clinical Context & Relevant Topics (1)

Disease Reference

Interstitial Lung Disease (ILD) in the ICU

Acute exacerbation and decompensated ILD: differential diagnosis, HRCT patterns, oxygen/NIV/HFNC, ventilation strategy, immunosuppression limits, and transplant decisions.

View Topic Context →